Lykke Advice aims to engage in the EU political sphere and to provide clients and readers with a unique view on specific topics, policies and debates related to EU public affairs. Occasionally, we also invite external authors to present their expert opinion on our blog.
The EU regulatory environment for artificial intelligence in healthcare is entering a phase of unprecedented activity. Companies developing AI-powered health solutions are no longer dealing
This opinion piece is part of a series on women’s health. After a first article on the vast gender health data gap in clinical trials and medical
This opinion piece is part of a series on women’s health. After covering the vast gender health data gap in clinical trials and medical research, we are dedicating
Despite representing more than half of the population, women are highly underrepresented in medical research. Moreover, gender-disaggregated results of clinical trials are usually absent. This leads to medicine, medical devices, diagnostic tools, surgery
After months of negotiations, the European Commission finally released, as part of a broader health package, the Safe Hearts Plan in December. This is the first-ever strategy at EU level dedicated
Life sciences in a snapshot Two weeks ago, the Commission released its Life Sciences Strategy named “Choose Europe for life sciences” a title reminiscent of
Health is one of the best examples of how European cooperation can deliver clear benefits for citizens across the EU. Among the most pressing health
Why cybersecurity in healthcare matters more than ever 208. This is the number of cyberattacks on the health sector reported to ENISA, the European Union
Rare diseases impact between 30 and 36 million people in the EU. To foster research, pooling scarce resources spread across the EU is essential.
The Covid-19 pandemic in 2020 triggered an epidemic of another kind: mental health issues. This was due to many reasons from social isolation measures to
